Security key
29384C108
Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA)
CUSIP: 29384C108
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 30,241,830
- Total 13F value
- $274,509,238
- Share change
- -404,398
- Put/Call ratio
- 28%
- SEC-reported price per share
- $9.04
- Number of holders
- 110
- Value change
- -$4,478,805
- Number of buys
- 45
- Number of sells
- 53
- Shares outstanding
- 38,346,880
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
110
Top holders
10
TRDA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Entrada Therapeutics, Inc. SEC filings
Entrada Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29384C108
Recent filing periods:
Ownership snapshot
Top reported holders of TRDA - Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ROCHE FINANCE LTD
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
15/15
Latest evidence
31 Dec 2024
13D/G
13F
Lead comparable stake: 6.9%
13D/G row: ROCHE FINANCE LTD
Showing 1-6 of 15 holder rows.
Quick read
ROCHE FINANCE LTD leads the comparable SEC ownership view at 6.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ROCHE FINANCE LTD's linked filing trail.
Comparable ownership
Top 5
ROCHE FINANCE LTD
6.9%
BlackRock, Inc.
5.3%
BAKER BROS. ADVISORS LP
13%
5AM Venture Management, LLC
11%
MPM ASSET MANAGEMENT LLC
11%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ROCHE FINANCE LTD |
13D/G
|
6.9%
|
$23,019,270
2,569,115 shares
|
$0 | 31 Dec 2024 |
| BlackRock, Inc. |
13F
13D/G
Company
|
5.3%
from 13D/G
|
$34,138,275
1,974,452 shares
|
— | 31 Dec 2024 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
13%
|
$84,130,011
4,865,819 shares
|
— | 31 Dec 2024 |
| 5AM Venture Management, LLC |
13F
Company
|
11%
|
$76,220,873
4,408,379 shares
|
— | 31 Dec 2024 |
| MPM ASSET MANAGEMENT LLC |
13F
Company
|
11%
|
$75,748,562
4,381,062 shares
|
— | 31 Dec 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
7.6%
|
$50,194,000
2,903,025 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
110
Shares
30,241,830
Rows available
110
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
110
Q1 2025 holders
110
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend